Health Archive » October, 2007

Health - October, 2007

174 articles

• SEC Sues Invitrogen Scientist For Insider Trading
• Judge Kicks Celebrex Investor Suit For Late Filing
• Alza Fights Bid For Attorney-Client Privileged Docs
• Ev3 To Pay $15.4M To Settle Two Patent Suits
• Judge Dismisses Prempro Suit Against Wyeth
• Wyeth Gets Wage-And-Hour Suit Dropped
• Bayer Fined $3.8M In Canada For Rubber Cartel
• Vitamin Shoppe Suit Tossed Amid Settlement Talks
• D.C. Drug Pricing Law Dies, Again
• Jones Day Adds IP Partner To Munich Office
• NLRB Vindicated By Circuit Over Union Ruling
• Bird Flu Vaccine Antitrust Suit Dismissed
• Lawmaker Needles FDA Over Avandia Vote Details
• New Rules 75, 78 Unfairly Penalize Research Entities
• AstraZeneca Wants To Boot Seroquel "Free-Riders"
• German Court Invalidates Lipitor Patent
• Dusa, River's Edge Settle Acne Drug Patent Dispute
• FEMA Formaldehyde Trailer Suits Consolidated
• Quigley Blasts Objections In Row Over President's Job
• Judge Certifies Forest Labs Shareholder Class
• Abbott Faces Antitrust Suit Over HIV Treatments
• Compromise Reached Over Mirapex Expert Witnesses
• Ruling Signals End Of Consumer Fraud Suits Over Ads
• After Raid, WellCare Facing Securities Suits
• Ruling Upheld In Appetite Stimulant Patent Feud
• Sanofi, Novo Spar In Insulin Pen Patent Suit—Again
• FTC Queries Blood Company Over Old Deals
• Multiproduct Sellers May Test PeaceHealth Standard
• Bayer Wins Avelox Infringement Case
• Sigma, Oxford Win Claims Construction Battle
• JPML Eyes Gadolinium Contrast Agent Cases
• Nobel Laureate's Fall Shows No Tolerance For Racism
• Bloomberg Renews Attack Over Calorie Posting
• Diomed Loses Another Summary Judgment Bid
• Tenn. Radiologists' Suit Revived After NicSand Ruling
• Plaintiff Alleges Glaxo Hid Avandia Risks
• Biovail, J&J Unit Hit Par With Third Ultram Suit
• Quigley Plan Gets Approval For Creditor Vote
• Aetna Hit With Shareholder Class Action
• Calif. Seeks To Rein In Rescission Practices
• AstraZeneca Told To Turn Over Salacious E-Mails
• Pfizer Seeks To Quash Report In Nigerian Drug Suit
• Yale Ordered To Pay $4.5M For Interfering With Union
• FDA Wants Another "Black Box" Warning For Avandia
• U.K. Court Lets Yeda Continue Case Over Erbitux
• Glaxo Relents, Grants Mylan Paxil License
• Generics Fight Nifedipine Direct Purchaser Class
• Lipitor Patent Upheld By Spanish Appellate Court
• Jury Says Roche's Mircera Infringed Amgen Patents
• Federal Circuit Affirms Calif.'s Immunity In Patent Suit
• FDA To Hold Hearing On Regulations On Salt In Food
• Bid To Dismiss Celexa Wrongful Death Suits Denied
• Astellas Resolves Adenoscan Disputes With Teva
• Medtronic Destroyed Defective Device: Suit
• FDA Pushes Back On So-Called Legacy Drugs
• Glaxo Sues Over Breathe Right Strips Patent
• Cozmed Stole Spinal Device Technology: Kyphon
• Med Tech Gets Behind Medtronic In High Court Brief
• Defendants In Vnus' Patent Suit Lose Invalidity Bid
• FDA Panel Seeks Wider Crackdown On Child Medicine
• FDA Announces Changes To ED Drug Labels
• Ex-National Century President Accused Of Tampering
• New Standard for Bundled Discounts Clear But Limited
• Zyprexa Whistleblower Wants To Switch Courts
• AstraZeneca Can Peek At Lilly Zyprexa Docs: Judge
• Health Care Providers Lose Bid To Toss Antitrust Case
• House Fails To Override Veto Of SCHIP Expansion
• FTC Opposes Antitrust Exemption For Pharmacists
• European Panel Revokes Symbicort Patent
• Bausch & Lomb Contact Lens Patent Settlement OK'd
• FDA Panel Mulls Child Medicine Crackdown
• Plaintiffs' Firms From Zyprexa Case Seek More Fees
• Seroquel Plaintiffs Appeal Dismissal Order
• SEC Investigates Medical Device Makers
• FDA Nets New Counsel Masoudi From DOJ
• Baxter Shareholder Can't Appeal Plaintiff Status: Court
• Pfizer Quibbles With Plaintiffs Over Mirapex Experts
• Boston Scientific Strikes Back In Stent Trial
• Wyeth To Contest Jury Verdict In Prempro Trial
• First Suits Hit Medtronic In Wake Of Advisory
• Former Government Adviser Joins Sonnenschein
• Swiss Defendants Get Accutane Claims Dismissed
• Giving The Go-Ahead To Use "Hybrid" Embryos
• Judge Tosses Hundreds From Bextra Case
• Fulbright Survives Patent Prosecution Malpractice Suit
• Judge Nixes Credit Suisse's Bid For More Time
• Oxycontin Maker Says Patents Are Enforceable
• Medtronic Stops Sales Of Defibrillator Part
• Duane Reade Employees Want Class Certification
• Jury Reconsiders $135M Verdict Against Wyeth
• Barr, Par Settle With Valeant Over Epilepsy Drug
• Judge Tosses Class Action Against Bausch & Lomb
• Mixed Ruling In Tyco, Ethicon Patent Suit
• Abbott Wants U.S. To Cough Up Docs In AWP Suit
• Acorda Sues Apotex Over Proposed Generic Zanaflex
• Sandoz Accuses Eli Lilly Of Inequitable Conduct
• Court Affirms Noninfringement Of Hypertension Drug
• Lawyers Want Wyeth To Hand Over Documents
• Cordis Says Aneurysm Device Claims Invalid
• Isolagen Underwriters Ask Judge For Reconsideration
• Drug Makers Yank Infant Cold Medicines
• Teva Sues Apotex, Marks 13th Coreg Suit In N.J.
• Hoffman-La Roche Told To Pay $7M To Accutane User
• Eisai Files Agreement With Generic Drugmakers
• Judge Lets Barr Build Up Arsenal For Yasmin Suit
• German Competition Regulators Raid Bayer
• NuvaRing Cases Combined For Remand Purposes
• Barr Strikes Back At Celgene In Thalomid Spat
• J&J Wins Dismissals In Ditropan XL Litigation
• PTO Invalidates Novartis Unit's HIV Diagnostic Patent
• Aredia Plaintiffs Lose Dental Monitoring Bid
• Three Days Into Trial, Cordis Hacks At Boston's Claims
• Jury Awards $130M In Wyeth Prempro Trial
• GE Hit With Another Suit Over Omniscan
• Depakote ANDA Didn't Violate Injunction: Court
• Doctor Says J&J/Cordis Stents Infringe Patent
• Boston Scientific Fights Bid To Remove Suit To State
• Schwarzenegger Bets Big On Statewide Health Care
• Amerigroup Faces Proposed FLSA Class Action
• Merck, Patients Fight Over Fosamax Discovery Tab
• FTC Pounds Infomercial Co. Over Weight Loss Claims
• Eli Lilly Adds Warning Labels To Zyprexa
• Takeda Wins Bid For Stay In Actos Patent Battle
• J&J Hits Back At Red Cross' Motion To Dismiss
• Mylan Strikes Back At Lilly In Strattera Patent Feud
• Circuit Court Tosses $42.5M Medco Settlement
• Iowa Takes On Drug Industry In New AWP Suit
• J&J Unit Sues Hologic For Patent Infringement
• GE Didn't Warn Patients Of MRI Drug's Risks: Suits
• Rembrandt, Bausch & Lomb To Settle Patent Dispute
• BSC Fights Bid To Block Thrombosis Info At Stent Trial
• Chase Medical Wins Patent Suit, Seeks Treble Award
• Abbott Fights Bid To Depose Ex-Pres In AWP Suit
• Sanofi Sues Mylan Over Prostate Drug — Again
• Stryker Opposes Stay Of Patent Case
• Avon Wins Lead Plaintiff Role In GSK Securities Suit
• HPV Patent Claims Are Unsustainable: Digene
• Varicose Vein Laser Patent Suit Heads To Trial
• Five Charged In Philly Cadaver Selling Scandal
• Former aaiPharma Execs Settle For $7.6M
• Becton Dickinson, Plaintiffs Pull Out Of Syringe MDL
• Florida Jury Hands Vioxx Win To Merck
• UCB, Dr. Reddy's, Others Settle Keppra Litigation
• States Sue Over Health Coverage Limits For Children
• FDA To Consider Behind-The-Counter Drugs
• Attorneys, Insurers Plan Appeal Of Hefty Sanctions
• Discovery To Commence In Invitrogen Patent Case
• AstraZeneca Gets Cases Tossed In Seroquel MDL
• Pfizer Wants Mirapex Claims Kicked To Curb
• FDA Reveals Plan To Speed Up Generic Drug Review
• Judge Unseals Some Data From Guidant MDL
• Haviland Leaves Suit With Sour Note For Berman
• Invitrogen Looks To Limit Damages From Patent Suit
• Lilly Seeks To Stay Whistleblower Suit Over Zyprexa
• Risperdal Fends Off Generic Competition
• Pfizer Execs Must Face Nigerian Clinical Trials Suit
• Celgene Amends Complaint In Thalomid Spat
• Judge Sides With Dentsply In Antitrust Case
• E-Z-EM Fights Back In Fluid Injector Patent Suit
• SEC Accuses Meridian Of $30M Accounting Gaffe
• Becton Settles Antitrust Suit Over Sharps Containers
• Glaxo Hit With Wrongful Death Suit Over Avandia
• FDA To Investigate Bone Drugs' Effects On Heart
• Parties Tussle Over Discovery In National Century Suit
• Spouse Of Triangle VP Settles Insider Trading Suit
• Apotex Wins As High Court Denies Pfizer Appeal
• Iovate Targets Nutrabolics Over Creatine Patents
• Attorneys Get $2.7M In PPA Case
• Boston Scientific, Cordis Face Off Over Damages
• Pepper Hamilton Lures Partner For Health Group
• High Court Rebuffs Medtronic Over Substitution
• Forcing Divestitures, FTC Gives Nod To Mylan Deal
• Becton Dickinson Targeted Hospital CEOs: Suit
• Drug Makers Fight Class Action Over Lice Treatment